top of page

BLUEBERRIES MEDICAL CORP ANNUAL GENERAL MEETING 2023

BBM FS Q1'24

BBM MD&A Q1'24

BBM S211 REPORT FOR 2023

INFORMACIÓN
GENERAL

Blueberries Medical Corp. es una compañía latinoamericana con todas las licencias otorgadas por los Ministerios de Justicia y Salud de Colombia, necesarias para producir cannabis de alta calidad, con bajos y altos contenidos de THC. Produce, comercializa, y exportar ingredientes derivados de Cannabis. Sus operaciones se centran principalmente en la Sabana de Bogotá, en el centro de Colombia.

Blueberries Medical Corp cotiza en los siguientes mercados: (CSE: BBM) (OTC: BBRRF) (FRA: 1OA)

PRESENTACIÓN INVERSIONISTAS

2023

Q4 2023

Audited Consolidated Financial Statements For The Year Ended December 31, 2023

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Twelve Months Ended December 31, 2023

Q3 2023

Condensed Interim Consolidated Financial Statements For The Three And Nine Months Ended September 30, 2023

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three And Nine Months Ended September 30, 2023

Q2 2023

Condensed Interim Consolidated Financial Statements For The Six Months Ended June 30, 2023

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Six Months Ended June 31, 2023

Q1 2023

Condensed Interim Consolidated Financial Statements For The Three Months Ended March 31, 2023

Management’s Discussion And Analysis Of Financial Condition And Results Of Operations For The Three Months Ended March 31, 2023

RELACIÓN CON INVERSIONISTAS

STOCK INFORMATION
bottom of page